Studies on the mechanism of rubidium-induced kaliuresis. Renal clearance and electron microprobe methods were used I) to elucidate the effects of chronic rubidium administration on potassium transport and 2) to localize, by the use of amiloride in acute experiments, the tubule site of interaction between rubidium and potassium. Substitution of drinking water by a 50 m rubidium chloride solution for 9 to 11 days led to significant hypokalemia (plasma potassium 2.5 0.1 mM; plasma potassium plus rubidium 3.3 0.1 mM). Compared to a control group (reduction of plasma potassium to 3.4 0.1 m by short-term potassium depletion) with a fractional potassium excretion of 2.1 0.3%, rubidium-treated rats excreted potassium at a much higher rate of 14.6 3.0%. The potassium content of principal cells was, however, significantly lower in rubidium-treated than in potassium-deprived animals. Similar to experiments in which rubidium was given acutely (3 hours), chronic rubidium administration was associated with preferential accumulation of rubidium in all tubule cells relative to potassium. Rubidium clearances were uniformly below those of potassium. Amiloride abolished the difference between rubidium and potassium clearances and sharply reduced the excretion of both cations. In view of the known site of action of amiloride, this suggests a distal tubule site of rubidium action on potassium transport. Amiloride also reduced or abolished the preferential uptake of rubidium into all but intercalated tubule cells. Marked cell heterogeneity of rubidium accumulation into intercalated cells was observed: One subpopulation, with low cell chloride, retained rubidium more effectively than another subpopulation with high cell chloride.
Studies on the mechanism of rubidium-induced kaliuresis. Renal clearance and electron microprobe methods were used I) to elucidate the effects of chronic rubidium administration on potassium transport and 2) to localize, by the use of amiloride in acute experiments, the tubule site of interaction between rubidium and potassium. Substitution of drinking water by a 50 m rubidium chloride solution for 9 to 11 days led to significant hypokalemia (plasma potassium 2.5 0.1 mM; plasma potassium plus rubidium 3.3 0.1 mM). Compared to a control group (reduction of plasma potassium to 3.4 0.1 m by short-term potassium depletion) with a fractional potassium excretion of 2.1 0.3%, rubidium-treated rats excreted potassium at a much higher rate of 14.6 3.0%. The potassium content of principal cells was, however, significantly lower in rubidium-treated than in potassium-deprived animals. Similar to experiments in which rubidium was given acutely (3 hours), chronic rubidium administration was associated with preferential accumulation of rubidium in all tubule cells relative to potassium. Rubidium clearances were uniformly below those of potassium. Amiloride abolished the difference between rubidium and potassium clearances and sharply reduced the excretion of both cations. In view of the known site of action of amiloride, this suggests a distal tubule site of rubidium action on potassium transport. Amiloride also reduced or abolished the preferential uptake of rubidium into all but intercalated tubule cells. Marked cell heterogeneity of rubidium accumulation into intercalated cells was observed: One subpopulation, with low cell chloride, retained rubidium more effectively than another subpopulation with high cell chloride.
A large number of transport studies supports the view that rubidium and potassium share many common features [1] [2] [3] [4] [5] [6] . Accordingly rubidium is frequently used as a marker ion for potassium. Studies employing renal clearance techniques [2] and flux measurements in single tubules [3] demonstrate that the renal excretion of rubidium and its movement across the wall of individual nephron segments are similar to that of potassium. However, significant differences have also been noted [2, [7] [8] [9] . Using clearance studies and electron microprobe analysis of single tubule cells, we showed in the rat that during the acute administration of rubidium chloride the renal clearance of rubidium is less than that of potassium, that rubidium enhances potassium excretion, and that rubidium is concentrated more than potassium in all tubule cell types of the kidney cortex [9] . potassium excretion and the concentrations of rubidium and potassium in individual renal tubule cells. Second, we investigated in clearance experiments the effects of amiloride on renal rubidium and potassium excretion. Amiloride is known to inhibit potassium secretion along the initial and cortical collecting tubule [10] [11] [12] [13] , nephron segments which play a major role in the regulation of renal potassium excretion. We argue that an inhibitory effect of this diuretic on both rubidium and potassium excretion would imply transport interaction of these cations at the nephron sites of potassium secretion.
Methods

Dietary pretreatment of the animals
The experiments were performed on male Wistar rats maintained on a standard rat diet (Altromin, Lage, FRG; potassium and sodium contents: 0.16 and 0.09 mol/kg) and tap water ad libitum. Three groups of animals were used.
In the first group (chronic rubidium; N = 6) rubidium was administered for 9 to 11 days by replacing the tap water with a solution containing 50 mmol rubidium chloride per liter.
In the second group (low K; N = 6). The standard diet was replaced for one to two days by a potassium-deficient diet (C 1037, Altromin, Lage, FRG; 3 mmol potassium per kg diet). The rationale of this procedure was to lower the plasma potassium concentration to levels equivalent to the sum of plasma potassium plus rubidium in group 1 so that the influence of different concentrations of potassium (plus rubidium) were minimized.
In the third group (amiloride; N = 5) standard diet and tap water were administered until the day of study.
Preparation of animals and experimental protocol
In general the methods were similar to those used in previous studies [9, [14] [15] [16] . Briefly, on the day of study the animals were anesthetized by i.p. injection of mactin (Byk-Gulden, Konstanz, FRG; 100 to 120 mg/kg body wt) and placed on a thermoregulated operating table to maintain body temperature at 37°C. The trachea, the right jugular vein, and the left femoral artery were cannulated with polyethylene catheters. The left kidney was approached via a flank incision, placed in a plastic cup, freed of adherent fat and connective tissue and kept under warm paraffin oil (38°C). The ureter was catheterized to allow collection of urine.
In the chronic rubidium and low potassium animals clearance studies were done at the end of the dietary treatment period. minutes of this period, in addition to rubidium chloride, amiloride (3 mg/hr/kg body wt) was administered intravenously. All infusion solutions contained 30 glliter polyfructosan (mutest, Laevosan-Gesellschaft, Linz, Austria). Blood which had been taken at the midpoint of each 30 minute clearance period was replaced quantitatively [9] .
To assess the role of circulating levels of aldosterone on renal potassium (rubidium) excretion in chronic rubidium and low potassium rats, plasma aldosterone levels were measured in seven rats kept on 50 m rubidium chloride as drinking solution for 10 days and in six rats maintained on a potassium deficient diet for two days.
Preparation of freeze-dried cryosections and determination of electrolyte contents
Following the clearance measurements the renal surface was cleansed and rinsed several times with warm (38°C) isotonic saline. Then the kidney was removed from the animal and shock-frozen in a 3:1 propane/isopentane mixture (-196°C) . Cryosections of about 1 sm thickness were cut in a modified ultracryomicrotome (Ultrotome V, LKB, Broma, Sweden) from the frozen tissue at -90°C, sandwiched between a collodion and a formvar film and freeze-dried at -80°C and 10_6 ton. A detailed description of the methods has been given previously [17] . Microprobe analysis of the freeze-dried sections was carried out in a scanning transmission electron microscope (S 150, Cambridge Instruments, Cambridge, UK) with an energy-dispersive X-ray detecting system (LINK Systems, High Wycombe, UK). Using an acceleration voltage of 20 kV and a probe current of 0.3 nA areas of about 1 m2 were scanned within the nuclei of the different tubule cell types for 100 seconds. The emitted X-rays were analyzed in the energy range between 0 and 20 keV. The rationale for restricting the analyses to the cell nuclei as well as the criteria for distinguishing between the different tubule cell types have been described previously [15, 161 . The cell element concentrations were calculated in mmol/kg dry wt from the peak/continuum ratios according to Hall [181. Chemical analyses and aldosterone assay Sodium and potassium concentrations in plasma and urine were measured by flame photometry (IL, Lexington, Massachusetts, USA). Rubidium concentrations in plasma and urine were determined by atomic absorption spectrophotometry (Pye Unicam, Cambridge, UK). Urine osmolality was measured by vapor pressure osmometry (Wescor, Logan, Utah, USA) inulin in plasma and urine by the anthrone method of FUhr, Kaczmarczyk and KrUttgen [191. Clearance data for potassium, rubidium, and sodium were calculated using standard formula. Plasma aldosterone concentrations were assessed by radioimmunoassay (Diagnostic Products Corp, Los Angeles, California, USA).
Presentation of data and statistical analysis
The data are presented as means SEM with (N) indicating the number of measurements. Comparisons between two groups of data were performed by t-test for paired or unpaired data as appropriate. Differences with P values less than 0.05 were regarded as significant. If more than two groups had to be compared, analysis of variance was carried out in a first step. Differences between individual groups were then tested in a second step by t-test using appropriately adjusted significance levels [20] .
Results
Plasma composition, plasma aldosterone levels and whole kidney functions following chronic rubidium administration and short-term potassium depletion Table 1 summarizes plasma electrolyte concentrations and plasma osmolalities in chronic rubidium and low potassium animals. While no significant differences in plasma sodium and chloride concentrations and in plasma osmolality were observed between the two groups, the plasma potassium concentration was significantly lower in the rubidium-treated group. The sum of plasma potassium plus rubidium concentrations in Values are means SEM. In each group 6 animals were studied. a Significantly different from corresponding value of rubidium-treated rats b Significantly different from fractional potassium excretion of rubidium-treated animals (by paired I-test) the chronic rubidium group (3.3 0.1 mM) was, however, similar to the plasma potassium concentration in the low potassium group (3.4 0.1 mM). Plasma aldosterone levels were assessed in a separate series of experiments. Data on plasma electrolyte concentrations in these animals are not shown, since values identical with those described above were obtained in both groups of animals.
Plasma aldosterone concentrations were not significantly different between rubidium-treated (22.5 3.1 ngldl; N = 7) and potassium-depleted (25.4 4.4 ngldl; N = 6) animals. In both the low potassium and chronic rubidium groups plasma aldosterone levels were significantly lower than in animals maintained on normal rat diet (574 9.2 ng/dl; N = 6). The changes in plasma aldosterone concentrations observed in chronic rubidium rats thus cannot account for the inappropriate potassium loss of these animals. Table 2 provides data on renal function in chronic rubidium and low potassium rats. Glomerular filtration rate was not different between rubidium-treated and potassium-deprived animals. Striking differences were, however, observed between intake were not responsible for the differences in urinary osmolalities. Furthermore, when the two groups of animals were challenged with an analogue of vasopressin, only a very modest increase in urine osmolality (from 1422 91 to 1519 119 mOsm/kg, P < 0.05 by paired I-test) was observed in the potassium-depleted rats. In rubidium-treated animals, the urine osmolality increased from an initially much higher value of 2372 243 to 2738 126 mOsm/kg (P < 0.05 by paired I-test). These results provide additional evidence that even modest potassium depletion compromises the urinary concentrating mechanism [231. Cell potassium and rubidium contents after short-term potassium depletion and following chronic rubidium ingestion Data on potassium and rubidium contents of individual tubule cells in chronic rubidium and low potassium rats are listed in Table 3 . It is evident that in proximal tubule, distal convoluted tubule, connecting tubule and principal cells rubidium replaces and effectively substitutes for potassium such that the sum of both cations in rubidium-treated animals is similar to the potassium content of low potassium rats. With respect to this latter group our data confirm the conclusions of both Orndt and Tannen [21] and of Linas et at [22] , who reported a sharp fall of urinary potassium excretion yet no major changes in renal tissue potassium content after one day [22] and after three days [211. In the present study (2-day potassium depletion), the potassium content of principal cells (626 mmoL/kg dry wt) is only modestly, but significantly (P < 0.02) reduced compared to a control group on normal potassium intake (670 mmollkg dry wt [91). Potassium deprivation for longer periods (14 to 22 days) resulted in a more pronounced fall in distal tubule cell potassium content by some 20% [14] .
Inspection of Values are means SEM with the number of cells in parentheses. In each group 6 animals were studied. The potassium contents of all tubule cell types in rubidium-treated rats are significantly different from the corresponding values in potassium-deprived animals (P <0.02)
Significantly different from sum of cell potassium plus rubidium content in rubidium-treated rats (P < 0.02) types were distinguished on the basis of their different rubidium content. Type I intercalated cells had a low, type II a high rubidium content, and these differences were associated with high and low potassium contents, respectively. The present study also shows that the two types of intercalated cells can be distinguished based on their different cell chloride contents [9] . The following data were obtained: type I cells in chronic rubidium rats had a chloride content of 135. Comparable values in low potassium animals were 162.0 7.8 (N = 44) and 24.9 4.1 (N = 37) mmol/kg dry wt, respectively. We also noted that after short-term potassium depletion the potassium content of both types of intercalated cells (717 and 644 mmollkg dry wt) was significantly higher than the potassium content, or the potassium plus rubidium content in control animals [9] , and in acutely [91 and chronically rubidium-loaded rats (intercalated cell type I: 631, 649 and 612 mmol/kg dry wt; intercalated cell type II: 583, 559 and 547 mmol/kg dry wt, respectively). In the absence of measurements of cell dry weight it is, however, not possible to obtain reliable estimates of cell potassium concentrations and, accordingly, some of the observed changes in cell ion content could be due to altered cell volume of the intercalated cell population.
Effect of amiloride on potassium and rubidium excretion Figure 1 depicts the effect of amiloride on renal potassium and rubidium excretion. Several points should be noted: First, following the start of rubidium administration the potassium excretion increased significantly [9] . Second, it is apparent that during the sustained rubidium administration, fractional potassium excretion uniformly exceeded that of rubidium. Finally, potassium and rubidium excretion dropped precipitously after amiloride administration. In the last clearance period the difference in fractional excretion rates between potassium and rubidium disappeared. Both the stimulating effect of rubidium on potassium excretion as well as the major source of rubidium in the final urine are thus localized at those distal nephron sites where amiloride exerts its action. Table 4 data are taken from [9) ; N = 6), from rats on 50 mM RbCl for 9 to II days (B; chronic rubidium animals of this study; N = 6) and from rats receiving RbCl and amiloride i.v. Following amiloride, there was a sharp drop in fractional potassium excretion from 92 to 19%. Fractional rubidium excretion, starting from a value of 64% before amiloride, dropped to 18.4%, a value not significantly different from that of potassium. Finally we observed a sharp increase in fractional sodium excretion after amiloride from 1.9 to 6.1%. Table 5 provides an overview of potassium and rubidium data of renal tubule cells following amiloride. A graphical summary of these data in comparison to those observed in acute 9] and and chronic rubidium-loading is given in Figure 2 . The most striking observation is the significant increase of the sum of potassium and rubidium content of all tubule cells following amiloride administration.
-
Discussion
One of the main observations of the present study was the sustained loss of potassium that occurred during chronic administration of rubidium. This extends our previous observation of significant stimulation of potassium excretion by acute administration of rubidium, a situation in which plasma potassium levels were initially normal [91. In the present series of experiments in which rubidium was administered for longer time periods (9 to Il days), potassium continued to be excreted at inappropriately high levels despite a significant fall in plasma potassium concentration. Whereas mildly hypokalemic animals, deprived of potassium for only two days, were able to sharply curtail urinary loss of potassium, animals in which comparable plasma levels of rubidium plus potassium were achieved by rubidium administration failed to conserve potassium. Since urine flow rate was lower following chronic rubidium intake than after short-term potassium depletion and urinary sodium excretion similar under both conditions, these factors cannot explain the inappropriate renal loss of potassium. We conclude from these data that rubidium exerts a powerful stimulating effect on potassium excretion.
Concerning the site of interaction between rubidium and potassium transport, we believe that indirect factors, such as Values are means SEM with the number of cell analyses in parentheses. The data were obtained from 5 kidneys. changes in tubule flow rate and sodium excretion do not play a role, since they were not changed in such a way as to account for stimulation of potassium excretion. Our experiments with amiloride provide strong evidence that a direct cellular effect at a distal tubule site is involved. This conclusion is based on two lines of evidence: First, administration of amiloride sharply reduced the fractional excretion of both cations. Second, this diuretic also abolished the difference of urinary excretion of rubidium and potassium that was typically observed. Accepting a distal site of rubidium and potassium secretion, the equal excretion rates of the two cations during amiloride administration suggest that both cations are similarly and extensively reabsorbed by the proximal tubule and the loop of Henle.
Principal cells of the initial and cortical collecting tubule have been identified as the main site of potassium secretion [13, [24] [25] [26] [27] [28] . It is therefore of interest to consider rubidium and potassium levels in these cells under conditions of chronic rubidium loading. Similar to results in acute rubidium-loading experiments [9] , we noted a sharp fall in potassium content at a time when potassium secretion was stimulated and plasma potassium levels had significantly declined. It is most reasonable to assume that the low potassium content after rubidium treatment reflects a proportionate fall in cell potassium concentration.' Accordingly enhanced secretion of potassium ions across the apical cell membrane cannot be mediated by an increase in the chemical driving force, because cell potassium declined and luminal potassium may safely be assumed to have increased in view of the high urinary potassium concentrations (160 mM) that accompanied the sustained kaliuresis. Hence, we are left with the possibilities of a specific effect of rubidium on either the apical potassium permeability or the apical electrical potential difference as the cause of stimulation of potassium secretion. Support for the hypothesis that these factors are important is the fact that cell potassium is partially replaced by rubidium, a cation that is less permeant than potassium [9, 30, 31] . Replacement of potassium by rubidium would depolarize the apical cell membrane, a factor known to stimulate potassium secretion [13, 32] . Potassium substitution can be expected to have a larger effect on the apical than basolateral potassium An estimate of principal cell potassium concentration can be obtained by comparing the mean value of the net potassium counts of all principal cells in chronic rubidium and low potassium rats with the mean net potassium counts determined in a large number of cryosections from a standard with known potassium concentration which had been cut separately from the renal tissue. If the conditions of sectioning are identical for standard and tissue the mean section thickness of standard and tissue should also be identical [29] . Using this approach, potassium concentrations of 88 and 122 mmol/kg wet wt are obtained in principal cells for chronic rubidium and low potassium rats, respectively.
efflux, because the intrinsic potassium permeability of the apical membrane exceeds that of the basolateral by a factor of 4 to 6 [33, 34] .
It is of interest that Palmer and Frindt [35] , in the apical membrane of the rat collecting tubule, and White et a! [361, in a distal tubule cell culture largely made up of principal cells, have observed a small conductance potassium channel with a high open probability that permits passage of both potassium and rubidium ions. It is possible that this channel plays a role in rubidium transport and the stimulation of potassium secretion by cytoplasmic rubidium. The significance of another potassium channel, discovered in the apical membrane of the rabbit and rat cortical collecting tubule [31] , in the rubidium-potassium interaction is unknown.
Our previous studies had indicated considerable accumulation of rubidium in all tubule cells [9] . We confirm these results in the present study. Figure 2 summarizes the potassium and rubidium contents of tubule cells following acute and chronic rubidium administration. Results obtained in acute experiments after amiloride are included for comparison, With exception of intercalated type II cells in which the rubidium content was almost twice that found in acute experiments, the rubidium content of all cells was slightly higher in chronic than in acute rubidium experiments. The higher cell rubidium content may have been caused by the higher plasma rubidium/potassium ratio since both cations are transported actively into tubule cells via the Na-K-ATPase.
The effects of amiloride on the distribution of potassium and rubidium in acutely rubidium-treated animals are also summarized in Figure 2 . As pointed out before, the sum of potassium and rubidium is higher in all cell types following amiloride administration. This is due largely to the selective increase in potassium content of proximal, distal convoluted tubule, connecting tubule, and principal cells. Assuming that the cell volume was not altered by amiloride, this increase in cell potassium plus rubidium content is equivalent to a rise in cell potassium plus rubidium concentration by about 15 mmol/kg wet wt.2 It is possible, but not certain that some of the following factors may be responsible for the increased cell potassium levels. In distal tubule cells with a significant apical sodium permeability, activity measurements in single Amphiuma collecting tubule cells have shown a fall of sodium of some 10 mmol/liter and a similar rise in potassium activity [37] . Thus replacement of sodium by potassium may contribute to the increase in cell potassium observed in the present experiments. 8 .0
1.1 Fig. 3 . Relation of cell to plasma ratios of rubidium to those of potassium in dfferent tubule cell types. Data (means SEM) were obtained in rats after 3 hours of RbCI infusion (black bars; data are from [9] ; N = 6), in rats on 50 mM RbCI for 9 to 11 days (open bars; chronic rubidium animals of this study; N = 6) and in rats receiving RbCI and amiloride iv. (hatched bars, amiloride group of this study; N = 5). Values above unity indicate preferential cell rubidium accumulation relative to potassium. *significantly different from data obtained after 3 hours of RbCI infusion, P < 0.025; significantly different from data observed in rats on 50 msi RbCI for 9 toll days, P <0.025.
This mechanism, however, cannot play a major role in those tubule cells in which amiloride-sensitive sodium channels do not constitute a major pathway of sodium entry. A second factor that may affect potassium uptake in all tubule cells is the pronounced increase in plasma potassium and rubidium concentrations during amiloride administration (Table 4) , because elevated plasma potassium levels are paralleled by increased cell potassium concentrations [9, 151. The present studies again demonstrate that rubidium is avidly taken up by all tubule cells [7, 9, 38] . Such displacement of potassium by rubidium has been shown to lead to significant depletion of potassium also in muscle cells [39] . This results in cell/plasma concentration ratios of rubidium to exceed those of potassium in conditions of acute and chronic rubidium loading, indicating preferential intracellular rubidium accumulation under these conditions. Figure 3 summarizes these results and also includes data of rubidium/potassium accumulation ratios in amiloride-treated animals. Two points should be noted. First, acute and chronic rubidium loading led to similar accumulation of rubidium in all tubule cells. One notable exception were intercalated cells of type II. In these significantly higher accumulation ratios were noted after the longer period of rubidium administration. Whereas steady state conditions are obtained in most tubule cells already after three hours, the kinetics of rubidium uptake and exit in intercalated type II cells are apparently much slower. This is apparent from the observation that, in contrast to all other cell types, chronic rubidium pretreatment led to a more extensive replacement of potassium.
We have pointed out previously that one possibility to explain preferential rubidium accumulation in tubule cells may be a lower passive rubidium efflux compared to that of potassium [9] . The alternative explanation of active uptake of rubidium exceeding that of potassium is unlikely, because selectivity of rubidium over potassium of the Na-K pump has not been observed [40] . The interpretation of lower rubidium than potassium permeability is consistent with experimental observations showing that single potassium channels discriminate between the two cations [30, 31, 41, 42] . Intercalated cells, although having fewer K channels in view of their low pump activity [16, 43], may contain perhaps an abundance of channels with low rubidium conductance. Inspection of Figure 3 shows that amiloride either diminishes or even abolishes the difference between rubidium and potassium accumulation in proximal tubule, distal convoluted tubule, connecting tubule and principal cells. This effect was absent in intercalated cells. Since amiloride impairs preferential rubidium accumulation in tubule cells that lack apical sodium channels, it is possible that diminished basolateral Na-H exchange may mediate the amiloride effect [44] . The precise mechanism of this action is not known, but may include alterations in cell pH. These may involve modulation of cation channel kinetics with loss of discrimination between potassium and rubidium. A direct inhibitory effect of amiloride upon basolateral Na-K pump activity and a secondary blocking effect on potassium conductance [37] is unlikely, because net transport of sodium is only inhibited in distal tubule cells having a significant apical amiloride-blockable sodium conductance.
Conclusions Chronic rubidium loading induces hypokalemia and sustained loss of potassium, Enhanced potassium excretion is independent of changes in plasma potassium and occurs despite a diminished potassium content of principal cells. Similar to acute rubidium loading chronic administration also leads to preferential cell rubidium retention, particularly in one subpopulation of intercalated cells. Amiloride sharply lowers the excretion of both potassium and rubidium and abolishes the difference of excretion of the two cations. These observations suggest a distal tubule site of rubidium secretion and of interaction between rubidium and potassium. .s \
